Imakethe yamasheya, ukuhwebelana kwamasheya namuhla
Ukucaphuna kwamasheya ezinkampanini ezingu-71229 ngesikhathi sangempela.
Imakethe yamasheya, ukuhwebelana kwamasheya namuhla

Izingcaphuno ze-Stock

Ukucaphuna kwamasheya ku-inthanethi

Umlando ucaphuna umlando

I-capital market capital

Izigaba ze-Stock

Inzuzo evela kumasheya enkampani

Imibiko yezezimali

Amanani wokulinganisa wezinkampani. Kukuphi ukutshalwa imali?

Izimali GlaxoSmithkline Pharmaceuticals Limited

Bika imiphumela yemali yenkampani GlaxoSmithkline Pharmaceuticals Limited, GlaxoSmithkline Pharmaceuticals Limited engenayo yonyaka ngonyaka ka-2024. GlaxoSmithkline Pharmaceuticals Limited ishicilela nini imibiko yezezimali?
Engeza kumawijethi
Ingeziwe kumawijethi

GlaxoSmithkline Pharmaceuticals Limited isamba semali engenayo, imali engenayo yonke kanye nezinguquko zezinguquko eziguqwini Rupee Indian namuhla

GlaxoSmithkline Pharmaceuticals Limited ngezikhathi zokubika ezimbalwa ezedlule. Amandla we- GlaxoSmithkline Pharmaceuticals Limited yehle ngo- -1 272 107 000 Rs kusukela ngesikhathi sokubika sokugcina. Imali engenayo ye-GlaxoSmithkline Pharmaceuticals Limited namuhla ifike ku- 1 108 300 000 Rs. Igrafu yenkampani yezimali GlaxoSmithkline Pharmaceuticals Limited. GlaxoSmithkline Pharmaceuticals Limited kugrafu ukhombisa amandla wempahla. GlaxoSmithkline Pharmaceuticals Limited imali engenayo ephelele kugrafu iboniswa iphuzi.

Usuku lokubika Ingqikithi yenzuzo
Imali engenayo ibalwa ngokuphindaphinda ubuningi bezimpahla ezithengiswa ngentengo yezimpahla.
futhi Ushintsho (%)
Ukuqhathaniswa kombiko wesinekota walo nyaka kanye nombiko wekota wonyaka odlule.
Imali engenayo
Imali engenayo iyinzuzo yebhizinisi ngaphandle kwezindleko zezimpahla ezithengisiwe, izindleko nezintela esikhathini sokubika.
futhi Ushintsho (%)
Ukuqhathaniswa kombiko wesinekota walo nyaka kanye nombiko wekota wonyaka odlule.
30/06/2020 6 485 900 000 Rs -17.688 % ↓ 1 108 300 000 Rs -2.387 % ↓
31/03/2020 7 758 007 000 Rs - 1 380 746 000 Rs -
31/12/2019 7 785 900 000 Rs -5.665 % ↓ -6 611 600 000 Rs -681.649 % ↓
30/09/2019 8 820 200 000 Rs - 5 027 500 000 Rs -
30/06/2019 7 879 700 000 Rs - 1 135 400 000 Rs -
31/12/2018 8 253 500 000 Rs - 1 136 700 000 Rs -
Bonisa:
Ukuze

Umbiko wezezimali GlaxoSmithkline Pharmaceuticals Limited, isimiso

Izinsuku zakamuva ze GlaxoSmithkline Pharmaceuticals Limited ezitholakala online: 31/12/2018, 31/03/2020, 30/06/2020. Izinsuku zezitatimende zezezimali zinqunywa yimithetho yokubalwa kwezimali. Usuku lwakamuva lombiko wezezimali we GlaxoSmithkline Pharmaceuticals Limited yi 30/06/2020. Imali engenayo yokusebenza GlaxoSmithkline Pharmaceuticals Limited iyisilinganiso sokuphendula esilinganisa inani lemali etholakalayo emisebenzini yebhizinisi, ngemuva kokunciphisa izindleko zokusebenza, njengeholo, ukwehla kwenani kanye nezindleko zezimpahla ezithengiswayo. Imali engenayo yokusebenza GlaxoSmithkline Pharmaceuticals Limited kuyinto 923 000 000 Rs

Izinsuku zembiko yezimali GlaxoSmithkline Pharmaceuticals Limited

Imali engenayo GlaxoSmithkline Pharmaceuticals Limited iyinzuzo yebhizinisi ngaphandle kwezindleko zezimpahla ezithengisiwe, izindleko nezintela esikhathini sokubika. Imali engenayo GlaxoSmithkline Pharmaceuticals Limited kuyinto 1 108 300 000 Rs Izindleko zokusebenza GlaxoSmithkline Pharmaceuticals Limited yizindleko ibhizinisi elizibandakanya ngenxa yokwenza imisebenzi yalo evamile yebhizinisi. Izindleko zokusebenza GlaxoSmithkline Pharmaceuticals Limited kuyinto 5 562 900 000 Rs Ukulingana GlaxoSmithkline Pharmaceuticals Limited yinani lazo zonke izimpahla zomnikazi ngemuva kokukhipha izikweletu eziphelele kumpahla ephelele. Ukulingana GlaxoSmithkline Pharmaceuticals Limited kuyinto 18 206 049 000 Rs

30/06/2020 31/03/2020 31/12/2019 30/09/2019 30/06/2019 31/12/2018
Inzuzo enkulu
Inzuzo eyinzuzo yinzuzo eyenziwa yinkampani ngemuva kokunciphisa izindleko zokukhiqiza nokuthengisa imikhiqizo yayo kanye / noma izindleko zokuhlinzeka ngezinsizakalo zayo.
3 912 600 000 Rs 4 792 077 000 Rs 4 508 400 000 Rs 5 121 500 000 Rs 4 571 800 000 Rs 4 427 700 000 Rs
Inani lentengo
Izindleko yizindleko eziphelele zokukhiqizwa nokusatshalaliswa kwemikhiqizo namasevisi yenkampani.
2 573 300 000 Rs 2 965 930 000 Rs 3 277 500 000 Rs 3 698 700 000 Rs 3 307 900 000 Rs 3 825 800 000 Rs
Ingqikithi yenzuzo
Imali engenayo ibalwa ngokuphindaphinda ubuningi bezimpahla ezithengiswa ngentengo yezimpahla.
6 485 900 000 Rs 7 758 007 000 Rs 7 785 900 000 Rs 8 820 200 000 Rs 7 879 700 000 Rs 8 253 500 000 Rs
Imali engenayo yokusebenza
Imali engenayo yokusebenza iyinzuzo evela ebhizinisini lenhloko yenkampani. Isibonelo, umthengisi udala imali engenayo ngokusebenzisa ukudayiswa kwezimpahla, kanti udokotela uthola inzuzo emisebenzini yezokwelapha ayinikezayo.
- - 7 785 900 000 Rs 8 820 200 000 Rs 7 879 700 000 Rs 8 253 500 000 Rs
Imali engenayo yokusebenza
Imali engenayo yokusebenza iyisilinganiso sokuphendula esilinganisa inani lemali etholakalayo emisebenzini yebhizinisi, ngemuva kokunciphisa izindleko zokusebenza, njengeholo, ukwehla kwenani kanye nezindleko zezimpahla ezithengiswayo.
923 000 000 Rs 1 638 123 000 Rs 1 060 600 000 Rs 1 713 100 000 Rs 1 462 300 000 Rs 1 251 100 000 Rs
Imali engenayo
Imali engenayo iyinzuzo yebhizinisi ngaphandle kwezindleko zezimpahla ezithengisiwe, izindleko nezintela esikhathini sokubika.
1 108 300 000 Rs 1 380 746 000 Rs -6 611 600 000 Rs 5 027 500 000 Rs 1 135 400 000 Rs 1 136 700 000 Rs
Izindleko ze-R & D
Izindleko zokucwaninga nezentuthuko - izindleko zocwaningo zokuthuthukisa imikhiqizo nezinqubo ezikhona noma ukuthuthukisa imikhiqizo nezinqubo ezintsha.
- - - - - -
Izindleko zokusebenza
Izindleko zokusebenza yizindleko ibhizinisi elizibandakanya ngenxa yokwenza imisebenzi yalo evamile yebhizinisi.
5 562 900 000 Rs 6 119 884 000 Rs 6 725 300 000 Rs 7 107 100 000 Rs 6 417 400 000 Rs 7 002 400 000 Rs
Amafa wamanje
Izimpahla zamanje ziyingxenye yebhalansi emela ukubaluleka kwazo zonke izimpahla ezingashintshwa zibe yikheshi phakathi nonyaka owodwa.
- 17 748 814 000 Rs - 16 130 400 000 Rs - -
Inani lempahla
Ingqikithi yempahla iyinani elilingana nengqikithi yenani eliphelele lenhlangano, amanothi esikweletu, nempahla ebonakalayo.
- 31 355 410 000 Rs - 35 195 400 000 Rs - -
Imali yamanje
Imali yamanje yimali yonke imali egcinwe yinkampani ngosuku lombiko.
- 1 048 115 000 Rs - 9 203 300 000 Rs - -
Isikweletu samanje
Isikweletu samanje siyingxenye yesikweletu esikhokhwa phakathi nonyaka (izinyanga ezingu-12) futhi siboniswa njengesibophezelo samanje kanye nengxenye yenani elisebenzayo.
- - - 8 151 800 000 Rs - -
Inani lemali
Ingqikithi yenkokhelo yinani lazo zonke imali enkampani enayo kuma-akhawunti ayo, kufaka phakathi imali encane nemali ebanjwe ebhange.
- - - - - -
Isikweletu sonke
Ingqikithi yesikweletu iyinhlanganisela yesikweletu sesikhashana nesikhathi eside. Izikweleti zesikhashana esifushane yizo okufanele zibuyiselwe phakathi nonyaka. Isikweletu sesikhathi eside sihlanganisa zonke izikweletu okufanele zibuyiselwe ngemuva konyaka owodwa.
- - - 11 738 900 000 Rs - -
Isikweletu sesilinganiso
Ingqikithi yesamba semali ephelele yezimpahla yi-ratio yezezimali ekhombisa iphesenti yezimpahla zenkampani ezimele njengesikweletu.
- - - 33.35 % - -
Ukulingana
Ukulingana yinani lazo zonke izimpahla zomnikazi ngemuva kokukhipha izikweletu eziphelele kumpahla ephelele.
18 206 049 000 Rs 18 206 049 000 Rs 23 456 500 000 Rs 23 456 500 000 Rs 21 398 292 000 Rs -
Ukugeleza kwemali
Ukugeleza kwezimali kuyinani eliphelele lemali kanye nezilinganiso zemali ezihamba enhlanganweni.
- - - - - -

Umbiko wamuva wezezimali ngemali engenayo GlaxoSmithkline Pharmaceuticals Limited kwakungu-30/06/2020. Ngokombiko wamuva ngemiphumela yezezimali ye-GlaxoSmithkline Pharmaceuticals Limited, imali engenayo ye-GlaxoSmithkline Pharmaceuticals Limited yayingu-6 485 900 000 Rupee Indian futhi ishintshwe yaba ngu--17.688% uma kuqhathaniswa nonyaka odlule. Inzuzo enenetha ye GlaxoSmithkline Pharmaceuticals Limited engxenyeni yokugcina yayingu-1 108 300 000 Rs, inzuzo enenzuzo ishintshwe ngu--2.387% uma kuqhathaniswa nonyaka odlule.

Izindleko zamasheya GlaxoSmithkline Pharmaceuticals Limited

Izezimali GlaxoSmithkline Pharmaceuticals Limited